1403501-24-5

Basic information

• Product Name: tert-butyl 4-(1-cyano-6-ethyl-4-(4-methoxyphenyl)-2-(methylthio)-5-oxo-5,6-dihydrobenzo[c][2,7]naphthyridin-8-yl)piperazine-1-carboxylate
• Synonyms: tert-butyl 4-(1-cyano-6-ethyl-4-(4-methoxyphenyl)-2-(methylthio)-5-oxo-5,6-dihydrobenzo[c][2,7]naphthyridin-8-yl)piperazine-1-carboxylate
• CAS NO: 1403501-24-5
• Molecular Weight: 585.727
• Mol File: 1403501-24-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(1-cyano-6-ethyl-4-(4-methoxyphenyl)-2-(methylthio)-5-oxo-5,6-dihydrobenzo[c][2,7]naphthyridin-8-yl)piperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(1-cyano-6-ethyl-4-(4-methoxyphenyl)-2-(methylthio)-5-oxo-5,6-dihydrobenzo[c][2,7]naphthyridin-8-yl)piperazine-1-carboxylate(1403501-24-5)
• EPA Substance Registry System: tert-butyl 4-(1-cyano-6-ethyl-4-(4-methoxyphenyl)-2-(methylthio)-5-oxo-5,6-dihydrobenzo[c][2,7]naphthyridin-8-yl)piperazine-1-carboxylate(1403501-24-5)

Safety Data

• Hazardous Substances Data: 1403501-24-5(Hazardous Substances Data)

Upstream product

• 2881-83-6 ethyl 4-methoxybenzoylacetate 
• 1403501-09-6 tert-butyl 4-(4-(3-cyano-5-(ethoxycarbonyl)-6-(4-methoxyphenyl)-2-(methylthio)pyridin-4-yl)-3-nitrophenyl) piperazine-1-carboxylate 
• 1403501-08-5 tert-butyl 4-(4-(3-cyano-5-(ethoxycarbonyl)-6-(4-methoxyphenyl)-2-(methylthio)-1,4-dihydropyridine-4-yl)-3-nitrophenyl)piperazine-1-carboxylate 
• 1403501-07-4 tert-butyl 4-(4-(3-amino-2-cyano-3-thioxoprop-1-enyl)-3-nitrophenyl)piperazine-1-carboxylate 
• 904896-12-4 tert-butyl 4-(4-formyl-3-nitrophenyl)piperazine-1-carboxylate 
• 1403501-11-0 tert-butyl 4-(1-cyano-4-(4-methoxyphenyl)-2-(methylthio)-5-oxo-5,6-dihydrobenzo[c][2,7]naphthyridin-8-yl)piperazine-1-carboxylate 
• 75-03-6 ethyl iodide 

Relevant articles and documents

TRI - AND TETRACYCLIC PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS AS ANTINEOPLASTIC AGENT

The present invention relates to compounds of following general formula (I): and to the pharmaceutically acceptable salts of same, the tautomers of same, the stereoisomers or mixture of stereoisomers in any proportions of same, such as a mixture of enantiomers, notably a racemic mixture, as well as to methods for preparing same and uses of same, notably as an antineoplastic agent.